liso-cel-话题@MedSci

#liso-cel#

5篇内容 | 1183人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2200612, encodeId=5e5b220061250, content=<a href='/topic/show?id=31978e07508' target=_blank style='color:#2F92EE;'>#苯达莫司汀#</a> <a href='/topic/show?id=4fa110931ac' target=_blank style='color:#2F92EE;'>#liso-cel#</a>, objectTitle=JHO：苯达莫司汀用于liso-cel前清淋的疗效和安全性, objectType=article, longId=823380, objectId=85948233804d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/man-by-modern-medical-equipment-RFTG5LW.jpg, objectUrl=/article/show_article.do?id=85948233804d, replyNumber=0, likeNumber=66, createdTime=2024-04-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=85948233804d, moduleTitle=JHO：苯达莫司汀用于liso-cel前清淋的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85948233804d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2193690, encodeId=b3f22193690f1, content=<a href='/topic/show?id=247743555b6' target=_blank style='color:#2F92EE;'>#大B细胞淋巴瘤#</a> <a href='/topic/show?id=02982402298' target=_blank style='color:#2F92EE;'>#二线治疗#</a> <a href='/topic/show?id=4fa110931ac' target=_blank style='color:#2F92EE;'>#liso-cel#</a>, objectTitle=Clin Cancer Res：FDA批准liso-cel用于大B细胞淋巴瘤二线治疗的相关临床试验, objectType=article, longId=817252, objectId=5e1a81e252e0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240316/1710562902043_6145188.jpg, objectUrl=/article/show_article.do?id=5e1a81e252e0, replyNumber=0, likeNumber=74, createdTime=2024-03-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5e1a81e252e0, moduleTitle=Clin Cancer Res：FDA批准liso-cel用于大B细胞淋巴瘤二线治疗的相关临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e1a81e252e0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1625985, encodeId=2f9a1625985f3, content=<a href='/topic/show?id=4fa110931ac' target=_blank style='color:#2F92EE;'>#liso-cel#</a>, objectTitle=Lancet：Liso-cel vs 标准疗法二线治疗原发难治性/早期复发性大B细胞淋巴瘤, objectType=article, longId=730182, objectId=b81ce30182de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b81ce30182de, replyNumber=0, likeNumber=150, createdTime=2022-06-23, rootId=0, userName=doctor-chen9589, userId=461320942612, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b81ce30182de, moduleTitle=Lancet：Liso-cel vs 标准疗法二线治疗原发难治性/早期复发性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b81ce30182de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1625984, encodeId=9092162598445, content=<a href='/topic/show?id=4fa110931ac' target=_blank style='color:#2F92EE;'>#liso-cel#</a>, objectTitle=Blood：采用CAR T细胞疗法(liso-cel)治疗复发性/难治性CLL/SLL, objectType=article, longId=220308, objectId=35f022030877, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35f022030877, replyNumber=0, likeNumber=0, createdTime=2021-11-15, rootId=0, userName=doctor-chen9589, userId=461320942612, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35f022030877, moduleTitle=Blood：采用CAR T细胞疗法(liso-cel)治疗复发性/难治性CLL/SLL, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35f022030877)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1625983, encodeId=9616162598342, content=<a href='/topic/show?id=4fa110931ac' target=_blank style='color:#2F92EE;'>#liso-cel#</a>, objectTitle=Lancet：Liso-cel治疗复发性/难治性大B细胞淋巴瘤活性好、安全性高, objectType=article, longId=200150, objectId=af16200150b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af16200150b6, replyNumber=0, likeNumber=0, createdTime=2020-09-04, rootId=0, userName=doctor-chen9589, userId=461320942612, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af16200150b6, moduleTitle=Lancet：Liso-cel治疗复发性/难治性大B细胞淋巴瘤活性好、安全性高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af16200150b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1625982, encodeId=b39816259824f, content=<a href='/topic/show?id=4fa110931ac' target=_blank style='color:#2F92EE;'>#liso-cel#</a>, objectTitle=FDA批准Liso-cel治疗B细胞淋巴瘤的优先审查, objectType=article, longId=188100, objectId=0b4e188100f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b4e188100f8, replyNumber=0, likeNumber=81, createdTime=2020-02-16, rootId=0, userName=doctor-chen9589, userId=461320942612, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b4e188100f8, moduleTitle=FDA批准Liso-cel治疗B细胞淋巴瘤的优先审查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b4e188100f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1625981, encodeId=6039162598146, content=<a href='/topic/show?id=4fa110931ac' target=_blank style='color:#2F92EE;'>#liso-cel#</a>, objectTitle=百时美施贵宝宣布向FDA申请其CAR-T细胞疗法liso-cel的许可, objectType=article, longId=184956, objectId=2ccf1849567a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ccf1849567a, replyNumber=0, likeNumber=0, createdTime=2019-12-21, rootId=0, userName=doctor-chen9589, userId=461320942612, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ccf1849567a, moduleTitle=百时美施贵宝宣布向FDA申请其CAR-T细胞疗法liso-cel的许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ccf1849567a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

liso-cel

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#苯达莫司汀# #liso-cel#

JHO：苯达莫司汀用于liso-cel前清淋的疗效和安全性

2024-04-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#大B细胞淋巴瘤# #二线治疗# #liso-cel#

Clin Cancer Res：FDA批准liso-cel用于大B细胞淋巴瘤二线治疗的相关临床试验

2024-03-17发表于上海

doctor-chen9589 (审核中...)

前往app查看评论内容

#liso-cel#

Lancet：Liso-cel vs 标准疗法二线治疗原发难治性/早期复发性大B细胞淋巴瘤

2022-06-23

doctor-chen9589 (审核中...)

前往app查看评论内容

#liso-cel#

Blood：采用CAR T细胞疗法(liso-cel)治疗复发性/难治性CLL/SLL

2021-11-15

doctor-chen9589 (审核中...)

前往app查看评论内容

#liso-cel#

Lancet：Liso-cel治疗复发性/难治性大B细胞淋巴瘤活性好、安全性高

2020-09-04

doctor-chen9589 (审核中...)

前往app查看评论内容

#liso-cel#

FDA批准Liso-cel治疗B细胞淋巴瘤的优先审查

2020-02-16

doctor-chen9589 (审核中...)

前往app查看评论内容

#liso-cel#

百时美施贵宝宣布向FDA申请其CAR-T细胞疗法liso-cel的许可

2019-12-21

科室
- - 订阅+
  - 更多科室
工具
服务